1. In this randomized controlled trial, low-dose intracoronary alteplase given early during primary percutaneous coronary intervention (PCI) for acute ST-Elevation Myocardial Infarction (STEMI) did not reduce microvascular obstruction.
2. Health related quality of life was not improved with low-dose intracoronary alteplase.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Acute coronary thrombosis causes...